期刊
METABOLITES
卷 7, 期 2, 页码 -出版社
MDPI
DOI: 10.3390/metabo7020029
关键词
isocitrate dehydrogenase; glioma; glioblastoma; 2-hydroxyglutarate; magnetic resonance spectroscopy
资金
- NorthWest Cancer Research Centre, Liverpool, UK
Mutations in the isocitrate dehydrogenase (IDH) 1/2 genes are highly prevalent in gliomas and have been suggested to play an important role in the development and progression of the disease. Tumours harbouring these mutations exhibit a significant alteration in their metabolism resulting in the aberrant accumulation of the oncometabolite 2-hydroxygluarate (2-HG). As well as being suggested to play an important role in tumour progression, 2-HG may serve as a surrogate indicator of IDH status through non-invasive detection using magnetic resonance spectroscopy (MRS). In this review, we describe the recent efforts in developing MRS methods for detection and quantification of 2-HG in vivo and provide an assessment of the role of the 2-HG in gliomagenesis and patient prognosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据